Her2-low tumors constitute a distinct, highly prevalent subgroup with specific clinical features, necessitating differentiated diagnostic and therapeutic approaches, and attention to molecular profiling, standardization of diagnostic methods, and the development of cost-effective strategies are essential for equitable...
M.Hossein Mirasheh, Zahra Shahabinia, M. Abusalah et al.· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.